Snibe, as a silver sponsor with a 96 sqm booth (Booth 20 in Hall A), attended the EUROMEDLAB Athens 2017 – the 22nd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, from June 12 to 14 in Athens, Greece, at the Megaron Athens International Conference Centre. 

With the vision to build closer connection with the doctors and specialists, Snibe attached most importance to sharing its latest technologies and to build its brand image. During the exhibition, Snibe showcased a wide variety of products, including Biolumi 8000 (The Integrated System) and MAGLUMI 4000 Plus, MAGLUMI 800, MAGLUMI 2000 Plus, MAGLUMI 2000, and MAGLUMI 1000 (the chemiluminescence immunoassay system), which became one of the light spots in the show and caught a lot of attention from the end users and distributors who came from all around the world.

MAGLUMI 4000 Plus, the latest product from chemiluminescence immunoassay system, with its compact design, throughput of 280 tests/hour, on-board capability up to 144 samples and time to first result of 16 minutes attracted many specialists’ eyes.

Biolumi 8000, the modular system combining immunology, biochemistry, electrolyte, and sample handing modules together, with merits of high efficiency, more convenience, top quality, and enhanced reliability, is full expansion and flexible recombination to satisfy all the different requirements in the laboratory. 

Snibe is dedicated to the R&D of immunoassay products for more than 22 years. With continuous efforts, 8000 unit instruments have been installed in 123 countries, which get positive feedback continually. With its mission and vision to be a professional pioneer in global in vitro diagnosis field, Snibe will never stop its step in improving human health life.

Thank you for visiting us on Booth 20 in Hall A!


Why is The Government So Bad at Health Care?

 

randox

Digital version